Li, L. et al. 2022. Efficacy and safety of osimertinib for patients with EGFR-mutated NSCLC: a systematic review and meta-analysis of randomized controlled studies. Acta Oncologica. 61, 11 (Nov. 2022), 1347–1353. DOI:https://doi.org/10.1080/0284186X.2022.2132116.